Epstein-Barr virus DNA associated with gastric adenocarcinoma and adjacent non-cancerous mucosa in patients from Manaus, Brazil.

Gastric cancer is one of most frequent causes of death in Brazil. The city of Manaus has one of the highest incidences of this disease in Brazil. The Epstein-Barr virus (EBV) is a ubiquitous herpesvirus that is classified as a group 1 carcinogen by the International Agency for Research on Cancer. We obtained biopsies from 6 control subjects and 10 patients with gastric carcinomas living in Manaus. In the patients, the samples were taken from tumors and from adjacent non-cancerous mucosa. These samples were screened for EBV DNA by PCR to amplify the 288-bp fragments from the Bam M region. The EBV DNA was detected in 8 of the 10 tumor cases and in none of the 6 control subjects. In the positively identified samples, EBV DNA was detected in five corresponding resection margins. Previous research indicated only a weak association between EBV and gastric cancer. We suggest that EBV should be considered as a risk factor for gastric adenocarcinomas in Manaus.

Metodologia para teste de tetrazólio em sementes de Amburana cearensis (Allemão) A.C. Smith / Methodology for tetrazolium test in Amburana cearensis (Allemão) A.C. Smith seeds

Objetivou-se com este trabalho estudar a metodologia do teste de tetrazólio para sementes de Amburana cearensis (Allemão) A.C. Smith, determinando as melhores condições de pré-umedecimento, bem como temperatura, período de coloração e concentração da solução de tetrazólio. Avaliou-se a coloração das sementes intactas e escarificadas (lixadas), ambas com tegumento, diretamente na solução de tetrazólio nas concentrações de 0,025; 0,050; 0,075 e 1 por cento a 35 e 40ºC, por 12 e 24h no escuro. Verificou-se o pré-umedecimento para retirar o tegumento utilizando-se sementes intactas e escarificadas, as quais foram imersas diretamente em água e submetidas a embebição em papel toalha e por 12, 24, 36 e 48 horas em temperaturas de 35 e 40ºC. Após a determinação do método para retirar o tegumento os embriões foram submetidas à coloração em solução de tetrazólio nas concentrações de 0,025; 0,050; 0,075 e 1 por cento. Com os resultados obtidos verificou-se a necessidade da retirada total do tegumento para que ocorra a coloração e que a temperatura de 40ºC é prejudicial para a embebição no pré-umedecimento. O teste de tetrazólio nas sementes de A. cearensis deve ser realizado com o pré-umedecimento das sementes escarificadas (lixadas) e imersas diretamente em água por 24 horas, na temperatura de 35ºC, para posterior retirada total do tegumento. E para atingir a coloração ideal os embriões devem ser imersos em solução de tetrazólio a 0,05 por cento por 3 horas, a 40ºC.

This work aimed to evaluate the methodology of tetrazolium test in Amburana cearensis (Allemão) A.C. Smith seeds, establishing the best pre-moistening conditions, as well as temperature, coloration period and tetrazolium solution concentration. The coloration of intact and scarified (sanded) seeds, both with tegument, was directly evaluated in tetrazolium solution at the concentrations of 0.025; 0.050; 0.075; and 1 percent, at 35 and 40ºC, for 12 and 24 h in the dark. Pre-moistening to remove the tegument was evaluated by using intact and scarified seeds, which were directly immersed in water and subjected to imbibition in paper towel for 12, 24, 36, and 48 h at 35 and 40ºC. After establishing the method to remove the tegument, embryos were subjected to coloration in tetrazolium solution at the concentrations of 0.025; 0.050; 0.075; and 1 percent. Based on the obtained results, the complete tegument removal is needed for coloration; besides, the temperature of 40ºC is harmful for imbibition during pre-moistening. The tetrazolium test in A. cearensis seeds should be performed including pre-moistening through direct immersion of scarified (sanded) seeds in water for 24h at 35ºC for later complete tegument removal. To achieve the ideal coloration, embryos must be immersed in tetrazolium solution at 0.05 percent for 3h at 40ºC.

Serum potassium concentrations after suxamethonium in patients with familial amyloid polyneuropathy type I.

BACKGROUND: Suxamethonium produces an abnormal increase in serum potassium in some neurological diseases and some authors have suggested that it is safer not to use this drug in patients with familial amyloid polyneuropathy (FAP). However, there are no data previously reported to support this hypothesis. The aim of this study was to evaluate the magnitude of the potassium increase produced by suxamethonium in FAP type I. METHOD: Twenty-one FAP Met 30 patients anaesthetised for liver transplantation were studied. Age was 34.9 +/- 6.9 years (mean +/- SD), time elapsed from first symptom 5.5 +/- 3.2 years and weight was 14 +/- 9% below ideal body weight. Anaesthesia was induced with thiopentone and low-dose fentanyl. Samples for blood gas and 5 min after 1 mg/kg of suxamethonium was given for tracheal intubation. RESULTS: Before induction serum potassium levels were 3.8 +/- 0.4 mmol/L. One minute after suxamethonium, values were 3.8 +/- 0.4 mmol/L and 5 min after 4.3 +/- 0.5 mmol/L. The maximal increase observed was 1.6 mmol/L (from 3.4 mmol/L to 5.0 mmol/L). CONCLUSION: The average increase in plasma potassium concentrations observed in FAP patients after suxamethonium was similar to the increase observed in a normal population by others. Our study can exclude the hypothesis that an anomalous increase in potassium would be a typical and frequent response to suxamethonium in FAP met 30 patients. However, we cannot exclude that a dangerous rise in serum potassium may exist in a certain percentage of FAP patients.